International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia
Adalgisa Condoluci(Ente Ospedaliero Cantonale), Davide Rossi(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Petra Langerbeins(University of Cologne), Silke Gillessen(Institute of Oncology Research), Robin Foà(Sapienza University of Rome), Sameer A. Parikh(Mayo Clinic), Lodovico Terzi di Bergamo(Institute of Oncology Research), Georg Stüssi(Institute of Oncology Research), Julio Delgado(Departament de Salut), Massimo Gentile(Azienda Ospedaliera di Cosenza), Lorenzo De Paoli(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Richard Rosenquist(Karolinska University Hospital), Stephan Stilgenbauer(Universität Ulm), Karin E. Smedby(Karolinska University Hospital), Giorgia Chiodin(University of Southampton), Francesca Romana Mauro(Sapienza University of Rome), Fortunato Morabito(Azienda Ospedaliera di Cosenza), Mattias Mattsson(Uppsala University Hospital), Riccardo Moia(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Manlio Ferrarini(North Shore University Hospital), Carmen Herling(University Hospital Leipzig), Gianluca Gaïdano(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Antonino Neri(University of Milan), Michael Doubek(Central European Institute of Technology), Michele Ghielmini(Institute of Oncology Research), Franco Cavalli(Institute of Social and Preventive Medicine), B. Gerber(University of Zurich), Manuela A. Hoechstetter(Ludwig-Maximilians-Universität München), Jana Kotašková(Central European Institute of Technology), Emili Montserrat(Universitat de Barcelona), Šárka Pospı́šilová(Central European Institute of Technology), Jasmin Bahlo(University Hospital Cologne), Michael Hallek(Integrated Oncology (United States)), Francesco Forconi(University of Leeds), Kari G. Rabe(Mayo Clinic), Clara Deambrogi(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Tycho Baumann(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Hartmut Döhner(University Hospital Ulm), William G. Wierda(University of Maryland, Baltimore), Wei Wu(Jiangsu Cancer Hospital), Elena Bianchi(Institute of Oncology Research), Emanuele Zucca(Università della Svizzera italiana), Valeria Spina(Ente Ospedaliero Cantonale), Alessio Bruscaggin(Institute of Oncology Research), Mark A. Hess(The University of Texas MD Anderson Cancer Center), Giovanna Cutrona(Ospedale Policlinico San Martino)
Cited by 139
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k